18 and older, any sex, with Oral Cancer. Patients with the condition only — healthy volunteers not accepted.
Results — posted to ClinicalTrials.gov
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of Dental Patients Who Strongly Agreed or Agreed That the Use of an Intra-Oral Camera By Their Dentists Helped Them to Better Understand Oral Cancer ScreeningPrimary· At the end of the dental appointment, 30-45 minutes
Consented patients will be asked to complete a brief Patient Exit Survey (5 statements) at the end of their dental appointments after being screened for oral cancer lesions using an intraoral camera. Responses to the second statement are reported for this outcome measure. The statement is scored on a Likert Scale from 1 - Strongly Disagree to 5 - Strongly Agree.
Group
Value
95% CI
Dental Patients
94.9
Percentage of Dental Patients Who Strongly Agreed or Agreed That Dentists Answered Their Questions About Oral Cancer and Were Able to Provide Them With ResourcesPrimary· At the end of the dental appointment, 30-45 minutes
Consented patients will be asked to complete a brief Patient Exit Survey (5 statements) at the end of their dental appointments after being screened for oral cancer lesions using an intraoral camera. Responses to the fourth statement are reported for this outcome measure. The statement is scored on a Likert Scale from 1 - Strongly Disagree to 5 - Strongly Agree.
Group
Value
95% CI
Dental Patients
94.8
Percentage of Dental Providers Who Reported Successfully Providing the Tele-Mentoring InterventionSecondary· At the end of the dental appointment, 30-45 minutes
Dentists are given a Provider "Essential Components" Checklist to fill out. This checklist summarizes the essential components of incorporating a tele-mentoring intervention into the identification of oral lesions via use of intraoral cameras to take photographs of oral lesions at chairside, uploading them into Dentrix, and conferring with an oral pathology expert.
Successful provision of the intervention is indicated by marking "item met" for all 10 intervention elements listed in the checklist.
Group
Value
95% CI
Dental Providers
100
Percentage of Dental Providers Who Reported That The Process Was Clear and StraightforwardSecondary· At the end of the dental appointment, 30-45 minutes
The process includes from EHR data entry to interaction with the oral surgeon over findings to patient referral
Group
Value
95% CI
Dental Providers
100
Sponsor's own description
The purpose of the proposed research project is to evaluate and enhance the feasibility and acceptability of integrating a tele-mentoring component into the identification of oral lesions at the 6 dental clinics of Family Health Centers at NYU Langone (FHC), a Federally Qualified Health Center (FQHC) in Brooklyn, NY.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
NCT07509619 — AI-based Physiotherapy Evaluation System for Range of Motion in Oral Cancer Patients
· recruiting
NCT07260344 — Evaluation of Two Non-Invasive Methods, High-Resolution Microendoscopy and Liquid-Based Cytology, for Detection of Oral
· NA
· recruiting
NCT06682494 — Enhancing Oral Cancer Awareness
· NA
· recruiting
NCT07095608 — Defining TRPV4 Contribution of Schwann Cells to Oral Cancer Pain
· NA
· recruiting
NCT07296250 — Circulating Tumor Cell Counts in Postoperative ENE-Positive Oral Cavity Cancer Patients After Adjuvant CCRT
· NA
· recruiting
Other NYU Langone Health trials
Trials by the same sponsor.
NCT07214519 — Permanent Supportive Housing Overdose Prevention-2 Study
· NA
· not yet recruiting
NCT05558267 — Potassium Containing Salt-Substitute in Hemodialysis-Dependent End Stage Kidney Disease
· NA
· not yet recruiting
NCT06637852 — Sexual and Urinary Function Improvement for Cancer Survivors
· NA
· not yet recruiting
NCT06236087 — Overdose Prevention Centers and Behavioral Health
· not yet recruiting
NCT06462027 — Packed Red Blood Cell Transfusion During Cardiac Arrest
· Phase 1
· suspended
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by NYU Langone Health
Last refreshed: 3 December 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04166214.